Cure My Disease

Don't miss your cure!

 Log in / Sign up

Infusion or bolus? study tests best steroid delivery for septic shock

NCT ID NCT07695337

Completed Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial compares two methods of giving hydrocortisone to adults with septic shock—a life-threatening drop in blood pressure due to infection. One group receives the steroid as a continuous drip, the other as intermittent shots every six hours. Researchers track 28-day survival, shock reversal, and recovery times to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hydrocortisone
What this could lead to
If one method proves better, it could become the standard way to give hydrocortisone for septic shock, potentially saving more lives.
What could go wrong
This is a single-center trial with 110 participants, so results may not apply broadly. The two methods may turn out to be equally effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPTIC SHOCK

Contacts and locations

Locations

  • Benha University Hospitals

    Banhā, Qalyubia Governorate, 13511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.